http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#Head http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#assertion http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#provenance http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#pubinfo http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#assertion https://uts.nlm.nih.gov/uts/umls/concept/C0012634 http://wordnet-rdf.princeton.edu/lemma/modifying https://uts.nlm.nih.gov/uts/umls/concept/C0003191 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#provenance http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#_assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC Project - version 4 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#_assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC version 3 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#_version http://www.w3.org/ns/prov#value 2 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#assertion http://www.w3.org/ns/prov#generatedAtTime 2023-07-20T09:47:08.673976 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#assertion http://www.w3.org/ns/prov#wasDerivedFrom https://doi.org/10.1007/s10067-021-05743-2 http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label anti-rheumatic drugs ( DMARDs ) http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label (106, 113) http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label modifying http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION http://www.w3.org/2000/01/rdf-schema#label 114, 123 http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label disease http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label (106, 113) http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.w3.org/2000/01/rdf-schema#label There is a paucity of high-quality evidence to guide The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs). http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:fcy3fn4c&rows=50 fcy3fn4c http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:fcy3fn4c-TRIPLE-ABSTRACT-8 fcy3fn4c-TRIPLE-ABSTRACT-8 https://uts.nlm.nih.gov/uts/umls/concept/C0003191 http://www.w3.org/2000/01/rdf-schema#label anti-rheumatic drugs https://uts.nlm.nih.gov/uts/umls/concept/C0012634 http://www.w3.org/2000/01/rdf-schema#label disease http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#pubinfo http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#sig http://purl.org/nanopub/x/hasPublicKey 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 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#sig http://purl.org/nanopub/x/hasSignature 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 http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc http://purl.org/np/RASOZ_N7BmvTKmiVdbMAZgLrfeAO1g-e0-NCs6ibRizJc http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377